Medicines Development professionals have the opportunity to breakdown industry silos and improve outcomes for patients across the globe. It is a collaborative journey, and the Academy’s esteemed programs not only impart textbook knowledge but serve to foster the social connections necessary for effective and meaningful adult learning and continuing education.
In our latest Interviews with the Academy segment, Jacob Coots, Director of Operations for GMDP Academy, discusses the importance of networking, learning from peers, and engaging with industry experts, making the hybrid model available through the Academy’s programs a transformative learning experience.
“Our hybrid model allows really, for those two pillars to shine, we have great course content, we have great lectures, we have great transcripts, all of that. But you could do that in another program, right? You could do that in another program, you can go and take an asynchronous course, it’s not guided, you’re not having any interaction, you don’t have industry experts that you can ask questions to, you just basically have a textbook with some exercises. At the GMDP Academy, we really lean into those other two things, we want you to network, we want you to learn from the other students. And we’re going to provide you with industry-leading experts that have lived this and are currently living this. They’re executives and pharma companies. They are advising the FDA and the EMA. You know, these are people that are doing what our students want to be doing. Right. And so that’s the magic of the hybrid model we’ve created.”
Ready to catapult your career? Apply here for our 2024 Certification in Medicines Development application.
Check out our YouTube channel for more Academy interviews and other great content.
Disclaimers
